Details

---

Manufacturer
Fresenius Kabi Oncology Limited(INDIA)
Registraction Number
MAL20016143AZ

Here’s the information about Gemita RTU 38mg/mL Injection:

Content

Active Ingredient: Gemcitabine hydrochloride (38 mg/mL), a nucleoside metabolic inhibitor with antitumor activity.
Excipients: Includes stabilizing agents such as propylene glycol and polyethylene glycol.

Indication

Used for the treatment of various cancers, including:
Non-small cell lung cancer.
Breast cancer.
Pancreatic cancer.
Urinary bladder cancer.
Ovarian cancer.

Instruction

Dosage:
The dose depends on the type of cancer, body surface area, and patient’s condition.
Administered under the supervision of a qualified healthcare professional.
Administration:
Given as an intravenous infusion.
Infusion duration and frequency depend on the specific treatment protocol.
Precautions:
Avoid use in patients with hypersensitivity to gemcitabine or its excipients.
Monitor for potential side effects such as nausea, vomiting, low blood cell counts, or fatigue.
Regular blood tests are required to monitor blood cells and organ function during treatment.